$HIPH American Premium Water Corp. (OTC:HIPH) Announces New

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
114
$HIPH American Premium Water Corp. (OTC:HIPH) Announces New Vanexxe Product Added to Wal-Mart.com

Vanexxe varicose vein treatment in smaller 1oz available for sale on Wal-Mart online channel


PLAYA VISTA, CA, March 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Premium Water Corporation (OTC: HIPH) announces that Canyon Create’s varicose vein cosmetic treatment, Vanexxe, is launching a new 1oz version available for sale on Walmart.com (https://www.walmart.com/ip/Vanexxe-Varicose-Vein-Support-Gel-1-Ounce/660299273). This product is being sold at a price point of $24.95, which is aimed to be at a more accessible level and on par with other ‘Over the Counter’ products, the category which Vanexxe will be positioned in the future.

American Premium CEO Ryan Fishoff commented, “I am excited to announce that Vanexxe is adding a new product to Wal-Mart.com. This is another accomplishment for Vanexxe, which has been gaining global recognition for its effective results in masking unsightly varicose veins. This past January, the Company announced a distribution deal in Australia. There are currently more distribution deals in the pipeline for other countries, but in the interim, the new 1oz version is now available for sale at a lower price point, opening the door for exposure to a different customer base that should increase visibility and sales. Vanexxe is a revolutionary product that cosmetically addresses painful and unsightly varicose veins; there is nothing on the market that fulfills this need at the price point and efficacy of Vanexxe.”

Vanexxe (www.vanexxe.com) uses a proprietary formulation to cosmetically remove varicose veins. The product works by simultaneously bringing heightened blood flow to the bulged vein valve, allowing it to pull away from the dermis and return to a more normal condition, and increases the elasticity in the upper skin layers to provide healthier skin, assisting in moving the vein back to a non-visible location. The Company made the agreement with Canyon Create back in November 2018.

“While the Company continues to focus on expanding distribution of all its brands and products, the recent COVID-19 (Coronavirus) outbreak has changed the retail climate. I don’t think there is any way to escape it. The key for the Company is to mitigate its impact on our continued efforts to expand distribution and increase sales. Launching our new products (100mg shots and CBD flavored water) remains a top priority. The Company received excellent feedback on these products at the CBD Expo and Champs Trade show. Numerous retailers and distributors expressed interest in placing orders. Recent events have paused the retail launch of these products. The Company continues to monitor the situation on ground. As it becomes clearer when things will return to normal, we will decide when the right time will be to launch the product in a proper manner. In the interim, we will focus on platforms like Walmart.com, Amazon, and other online channels which are currently seeing large increases in traffic.

“I do feel that the Company has a corporate and social responsibility to help in the effort to combat Coronavirus. I was quite moved by what LVMH did by switching their fragrance production line to produce hand sanitizer that will be distributed to the French population to help combat the spread of the virus. I am exploring ways that the Company can help and participate in the greater efforts to control this virus. We are evaluating ways that we can contribute to the cause without the Company deviating from its business plan. Under consideration is how we could potentially leverage our Hydro-Nano technology to create sanitizer products that could be more effective and efficient in eliminating germs. We are also exploring if our Hydro-Nano technology, combined with CBD, could, in any way, be helpful in treating the virus. I caution that there are so many unknowns at this juncture, but I do believe that it’s in the best interests of the Company to help contribute in the global fight against this pandemic, which ultimately I believe will be in the shareholders interest. I look forward to sharing progress with investors and the shareholder community in the coming weeks about our product launch initiatives and our contribution to the fight against the spread of Coronavirus,” concluded Mr. Fishoff

Vanexxe 2oz can be purchased on Amazon here.

Goldman Research initiated coverage of the Company on February 13th 2020, giving a $0.0125 price target. To read the full report, click here.

About American Premium Water Corp.

American Premium Water (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Q4 Sports (www.q4sports.com) Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) plant + body essentials (www.plantbodyessentials.com).

Safe Harbor Notice

Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.

This press release is issued on behalf of the Board of Directors of American Premium Water Corporation

Investor Relations
888-983-0054
info@americanpremiumwater.com

Source: American Premium Water Co.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading